ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 115 filers reported holding ADMA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $65,960 | -45.9% | 17,000 | -66.0% | 0.01% | -53.8% |
Q3 2022 | $122,000 | -22.8% | 50,000 | -37.5% | 0.01% | 0.0% |
Q2 2022 | $158,000 | -42.5% | 80,000 | -46.7% | 0.01% | -56.7% |
Q1 2022 | $275,000 | +29.7% | 150,000 | 0.0% | 0.03% | +30.4% |
Q4 2021 | $212,000 | -9.0% | 150,000 | -27.2% | 0.02% | -20.7% |
Q3 2021 | $233,000 | -11.1% | 206,000 | +25.6% | 0.03% | -12.1% |
Q2 2021 | $262,000 | +48.9% | 164,000 | +64.0% | 0.03% | +26.9% |
Q1 2021 | $176,000 | -9.7% | 100,000 | 0.0% | 0.03% | -16.1% |
Q4 2020 | $195,000 | +36.4% | 100,000 | +66.7% | 0.03% | -11.4% |
Q3 2020 | $143,000 | +146.6% | 60,000 | +200.0% | 0.04% | +84.2% |
Q2 2020 | $58,000 | – | 20,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 883,214 | $1,722,000 | 0.80% |
Telemetry Investments, L.L.C. | 200,615 | $391,000 | 0.66% |
Perceptive Advisors | 16,584,802 | $32,340,000 | 0.35% |
Consonance Capital Management LP | 1,558,290 | $3,039,000 | 0.28% |
683 Capital Management, LLC | 2,000,000 | $3,900,000 | 0.18% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 627,931 | $1,224,000 | 0.15% |
GSA CAPITAL PARTNERS LLP | 327,052 | $638,000 | 0.10% |
APOGEM CAPITAL LLC | 54,240 | $106,000 | 0.07% |
HUSSMAN STRATEGIC ADVISORS, INC. | 82,000 | $160,000 | 0.04% |
J. Goldman & Co LP | 376,319 | $734,000 | 0.04% |